Estera implements
eFront Invest AS & eFront Investment Café
eFront’s solutions will enable Estera to offer a powerful and professional service to private equity clients and intermediaries of substantial …
Oct 10, 2019
Axil Capital
implements eFront Invest GP
Axil Capital will benefit from eFront Invest GP’s suite of automated fund management tools encompassing intuitive accounting, advanced reporting and streamlined workflows within a centralized industry-leading solution. eFront Invest GP has now been adopted by more than 500 general partners and asset servicers worldwide.
“We chose eFront because it offers the most comprehensive solution for venture capital and private equity firms, encompassing all aspects of the investment life cycle. Adoption of eFront Invest GP will allow us to process large volumes of data, quickly and accurately. We were particularly attracted to eFront’s combination of ready-made template solutions that can be further customized to address our specific needs.”
Fred Shane, Axil Capital Managing Partner
Key Benefits
Intuitive accounting
Advanced reporting
Streamlined workflows
Centralized industry-leading solution
About Axil Capital
Firm type: general partner
Assets under management: $40 M
Geographical presence: Asia-PacificAxil Capital was spun out of Mizuho Securities in 2017, with early investors that include Mizuho, the Japanese government, a global pharma, and a small group of visionary investors from inside and outside of Japan. Its goal is to create synergies between the biotech ecosystem in Japan and the rest of the world, resulting in great companies and great returns for their investors. With one fund and 40M in assets under management, Axil focuses on innovation in biotechnology. Find more at axilcapital.com.
Assets under management: $40 M
Geographical presence: Asia-PacificAxil Capital was spun out of Mizuho Securities in 2017, with early investors that include Mizuho, the Japanese government, a global pharma, and a small group of visionary investors from inside and outside of Japan. Its goal is to create synergies between the biotech ecosystem in Japan and the rest of the world, resulting in great companies and great returns for their investors. With one fund and 40M in assets under management, Axil focuses on innovation in biotechnology. Find more at axilcapital.com.
Download the Brochure
Download the Brochure
Suggested content
Sumitomo Mitsui Asset Management
implements eFront Invest GP
SMAM searched for the best-in-class compliance system that would consolidate all its data and be able to support its future …
Dec 17, 2019
Acumen
eFront has been selected by the global venture fund, Acumen, as a one-stop solution for monitoring their investments and projects …
Jul 23, 2018